Projected Income Statement: Amphenol Corporation

Forecast Balance Sheet: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 3,603 3,205 2,862 3,569 4,371 11,415 8,043 4,722
Change - -11.05% -10.7% 24.7% 22.47% 161.13% -29.54% -41.29%
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/28/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 360.4 383.8 372.8 665.4 996.6 1,300 1,417 1,581
Change - 6.49% -2.87% 78.49% 49.77% 30.47% 8.95% 11.61%
Free Cash Flow (FCF) 1 1,180 1,791 2,156 2,157 4,393 5,982 6,988 8,036
Change - 51.8% 20.39% 0.06% 103.65% 36.17% 16.83% 15%
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/28/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 23.64% 23.77% 23.9% 25.46% 30.19% 32.11% 32.39% 32.19%
EBIT Margin (%) 20% 20.66% 20.66% 21.69% 26.2% 27.46% 28.09% 28.13%
EBT Margin (%) 18.29% 19.55% 19.55% 19.79% 24.25% 23.82% 25.97% 27.01%
Net margin (%) 14.63% 15.07% 15.36% 15.92% 18.49% 17.58% 19.4% 20.29%
FCF margin (%) 10.85% 14.19% 17.17% 14.17% 19.02% 17.88% 18.38% 19.06%
FCF / Net Income (%) 74.16% 94.14% 111.82% 88.99% 102.87% 101.73% 94.76% 93.98%

Profitability

        
ROA 11.78% 12.43% 11.74% 12.55% 14.82% 14.8% 16.34% 17.1%
ROE 27.22% 28% 24.35% 26.27% 36.82% 39.56% 37.44% 31.38%

Financial Health

        
Leverage (Debt/EBITDA) 1.4x 1.07x 0.95x 0.92x 0.63x 1.06x 0.65x 0.35x
Debt / Free cash flow 3.05x 1.79x 1.33x 1.65x 1x 1.91x 1.15x 0.59x

Capital Intensity

        
CAPEX / Current Assets (%) 3.31% 3.04% 2.97% 4.37% 4.32% 3.89% 3.73% 3.75%
CAPEX / EBITDA (%) 14.02% 12.79% 12.42% 17.17% 14.29% 12.1% 11.51% 11.65%
CAPEX / FCF (%) 30.55% 21.43% 17.29% 30.85% 22.69% 21.74% 20.27% 19.67%

Items per share

        
Cash flow per share 1 1.231 1.751 2.037 2.228 4.207 6.162 7.093 8.61
Change - 42.22% 16.36% 9.34% 88.88% 46.46% 15.11% 21.39%
Dividend per Share 1 0.3175 0.405 0.425 0.55 0.745 1.017 1.117 1.264
Change - 27.56% 4.94% 29.41% 35.45% 36.44% 9.92% 13.12%
Book Value Per Share 1 5.038 5.649 7.009 8.097 10.94 13.93 18.38 23.8
Change - 12.13% 24.09% 15.52% 35.05% 27.39% 31.94% 29.47%
EPS 1 1.27 1.53 1.555 1.92 3.34 4.602 5.708 6.664
Change - 20.47% 1.63% 23.47% 73.96% 37.78% 24.03% 16.76%
Nbr of stocks (in thousands) 1,196,056 1,190,189 1,196,620 1,205,613 1,224,056 1,230,234 1,230,234 1,230,234
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/28/26 - - -
1USD
Estimates
2026 *2027 *
P/E 35.8x 28.8x
PBR 11.8x 8.95x
EV / Sales 6.39x 5.54x
Yield 0.62% 0.68%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
164.59USD
Average target price
184.00USD
Spread / Average Target
+11.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APH Stock
  4. Financials Amphenol Corporation